Delivery Order SPE2DB20D1109-SPE2DB25FN76F

Award Date 3/20/25
Potential Completion Date 3/21/25
Potential Value $5.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,769.12 to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of testosterone cypionate 200 mg/mL medical injections. This order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $1,052.14 to supply Testosterone Cypionate 200 mg/ml. The contract has a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,055.40, is for the delivery of testosterone cypionate 200 mg/mL medication. The contract has a period of performance through July 24, 2024 and is a firm fixed-price type. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of testosterone cypionate 200 mg/mL. The award, valued at $1,911.32, has a firm fixed price and a completion date of September 24, 2024. The contract is not associated with a set-aside program. AmerisourceBergen, through its extensive supply chain network, provides a wide range of pharmaceutical products and medical supplies to support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of testosterone cypionate 200 mg/mL medication. The contract has a firm fixed price of $1,378.62 and a completion date of May 15, 2024. It is not associated with any set-aside program. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
This contract award to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, is a Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical for $2,310.37. The order is for testosterone cypionate 200 mg/mL, a prescription medication. This award is not set aside for any specific business category. The contract has an ultimate completion date of August 20, 2024 and is a Firm Fixed Price agreement. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,539.40 delivery order contract is for the supply of testosterone cypionate 200 mg/mL, a specialty medication. The contract has a firm fixed price pricing type and a completion date of December 9, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of testosterone cypionate 200 mg/mL. The contract has a ceiling value of $1,343.66 and is a firm fixed-price arrangement. The period of performance extends through September 5, 2024. This order appears to be part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FA8P1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,599.84, is for the delivery of testosterone cypionate 200 mg/ml medication. It is a firm fixed price delivery order contract with a completion date of March 3, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,189.22 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The contract is for the supply of 4,565,965,794 units of 2,000 mg/10 ml testosterone cypionate, a critical medication. The award has an ultimate completion date of September 30, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB25FN76F
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,787.64, is for the supply of testosterone cypionate 200 mg/mL injections. It is a firm fixed-price contract with a completion date of March 21, 2025. The contract is not designated as a set-aside.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 6/21/25, 9:48 AM